March 31 (Reuters) - The U.S. Federal Trade Commission said on Thursday it had filed a lawsuit accusing Endo International Plc of violating antitrust laws by striking "pay-for-delay" deals to block access to generic copies of its pain drugs.
Read more
No comments:
Post a Comment